Trevena, Inc. (TRVN)
NASDAQ: TRVN · IEX Real-Time Price · USD
0.238
-0.007 (-3.02%)
At close: Jul 19, 2024, 12:00 AM
0.253
+0.015 (6.30%)
Pre-market: Jul 22, 2024, 8:54 AM EDT
Trevena Employees
Trevena had 23 employees as of December 31, 2023. The number of employees decreased by 12 or -34.29% compared to the previous year.
Employees
23
Change (1Y)
-12
Growth (1Y)
-34.29%
Revenue / Employee
$136,478
Profits / Employee
-$1,745,565
Market Cap
4.37M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
OpGen | 100 |
Genetic Technologies | 60 |
Predictive Oncology | 35 |
Theriva Biologics | 22 |
Sonnet BioTherapeutics Holdings | 12 |
CERo Therapeutics Holdings | 9 |
Allarity Therapeutics | 6 |
MyMD Pharmaceuticals | 6 |
TRVN News
- 14 days ago - Trevena Announces $2M Non-Dilutive Financing Tranche and Reduction in Outstanding Liabilities in Connection with Existing ex-US Royalty Financing - GlobeNewsWire
- 4 weeks ago - What's Going On With Neurological Disease Focused Trevena On Thursday? - Benzinga
- 4 weeks ago - Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seizure Activity in Epilepsy Models - GlobeNewsWire
- 2 months ago - Trevena Reports First Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 4 months ago - Trevena Reports Fourth Quarter 2023 Results and Provides Corporate Update - GlobeNewsWire
- 7 months ago - Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant Exercise - GlobeNewsWire
- 7 months ago - Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant Exercise - GlobeNewsWire
- 8 months ago - Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual Meeting - GlobeNewsWire